Cancer metabolism is a rapidly growing area of research that explores how the altered metabolic processes in cancer cells support their uncontrolled growth and survival. Tumor cells often exhibit increased glucose uptake and preferential use of glycolysis, even in the presence of oxygen, a phenomenon known as the Warburg effect. This metabolic reprogramming not only promotes cell proliferation but also contributes to the resistance of cancer cells to chemotherapy and radiation. Researchers are identifying metabolic pathways and enzymes that could serve as therapeutic targets, aiming to disrupt these processes and selectively target cancer cells. A deeper understanding of cancer metabolism could lead to the development of novel treatments, including drugs that inhibit specific metabolic pathways, offering a potential new avenue for cancer therapy.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States